BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 1672252)

  • 1. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
    Coley HM; Workman P; Twentyman PR
    Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    Rhodes T; Barrand MA; Twentyman PR
    Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
    Coley HM; Amos WB; Twentyman PR; Workman P
    Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
    Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efflux of anthracyclines in multidrug-resistant cell lines.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
    Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
    Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein.
    Barrand MA; Rhodes T; Center MS; Twentyman PR
    Eur J Cancer; 1993; 29A(3):408-15. PubMed ID: 8398342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
    Twentyman PR; Rhodes T; Rayner S
    Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
    Versantvoort CH; Broxterman HJ; Bagrij T; Scheper RJ; Twentyman PR
    Br J Cancer; 1995 Jul; 72(1):82-9. PubMed ID: 7599070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
    Coley HM; Twentyman PR; Workman P
    Eur J Cancer; 1990; 26(6):665-7. PubMed ID: 1975502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
    Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
    Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
    Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
    Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
    Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
    Chiang CD; Song EJ; Yang VC; Chao CC
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
    Jensen PB; Christensen IJ; Sehested M; Hansen HH; Vindeløv L
    Br J Cancer; 1993 Feb; 67(2):311-20. PubMed ID: 8094293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
    Sehested M; Bindslev N; Demant EJ; Skovsgaard T; Jensen PB
    Biochem Pharmacol; 1989 Sep; 38(18):3017-27. PubMed ID: 2571333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.